“在新一代ADC技术的道路上,美国的Mersana并非独行者和技术垄断者。我国的诺灵生物医药科技(北京)有限公司(简称“诺灵”)也掌握了高分子偶联技术,其自主知识产权的技术平台与Mersana相比,不但毫不逊色,而且在药物代谢控制、药物释放方面更优。诺灵...查看全文
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-077365 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-072570 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070892 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070894 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070895 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070898 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070896 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070900 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-070408 Act: 34 Size: 206 KB 网页链接
$Mersana Therapeutics(MRSN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-062787 Act: 34 Size: 110 KB 网页链接